187
Views
56
CrossRef citations to date
0
Altmetric
Original Research

Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy

, &
Pages 4107-4119 | Published online: 12 Jul 2018

References

  • VermaSMilesDGianniLTrastuzumab emtansine for HER2-positive advanced breast cancerN Engl J Med20123681917831791
  • LiuFLiuSHeSSurvivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cellsOncol Rep20102351469147520372866
  • ChenHTianJLiuDHeWGuoZDual aptamer modified dendrigraft poly-l-lysine nanoparticles for overcoming multi-drug resistance through mitochondrial targetingJ Mater Chem B201755972979
  • KankalaRKTsaiPYKuthatiYOvercoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeuticsJ Mater Chem B20175715071517
  • ZhangMJingSZhangJIntracellular release of PluronicL64 unimers into MCF-7/ADR cells to overcome multidrug resistance by surface-modified PAMAMJ Mater Chem B201752139703981
  • AbrahamIJainSWuCPMarine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cellsBiochem Pharmacol201080101497150620696137
  • ZhaoDMaSYiXReversible core-crosslinked nanocarriers with pH-modulated targeting and redox-controlled drug release for overcoming drug resistanceJ Mater Chem B201754283998407
  • ShirakiNOkamuraKTokunagaJBromocriptine reverses P-glycoprotein-mediated multidrug resistance in tumor cellsJpn J Cancer Res200293220921511856485
  • WangJWangFLiFA multifunctional poly(curcumin) nanomedicine for dual-modal targeted delivery, intracellular responsive release, dual-drug treatment and imaging of multidrug resistant cancer cellsJ Mater Chem B20164172954296227152196
  • Xiao-aiLBeiWXiao-hongXCurcumin re-sensitizes multidrug resistant (MDR) breast cancer to cisplatin through inducing autophagy by decreasing CCAT1 expressionRSC Advances20177533357233579
  • MaXHuangXMooreZEsterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapyJ Control Release201520020121125542645
  • ChoiBTCheongJChoiYHBeta-Lapachone-induced apoptosis is associated with activation of caspase-3 and inactivation of NF-kappaB in human colon cancer HCT-116 cellsAnticancer Drugs2003141084585014597880
  • PlanchonSMWuerzbergerSFrydmanBBeta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent responseCancer Res19955517370637117641180
  • ZhangLChenZYangKβ-Lapachone and paclitaxel combination micelles with improved drug encapsulation and therapeutic synergy as novel nanotherapeutics for NQO1-targeted cancer therapyMol Pharm201512113999401026415823
  • YeMHanYTangJA tumors-specific cascade amplification drug release nanoparticle for overcoming multidrug resistance in cancersAdv Mater20172938
  • WangCChenSYuQHuFYuanHTaking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cellsJ Mater Chem B201751120682073
  • ZhaoZLouSHuYZhuJZhangCA nano-in-nano polymer-dendrimer nanoparticle-based nanosystem for controlled multidrug deliveryMol Pharm20171482697271028704056
  • VogusDRPusuluriAChenRMitragotriSSchedule dependent synergy of gemcitabine and doxorubicin: improvement of in vitro efficacy and lack of in vitro-in vivo correlationBioeng Transl Med201831495729376133
  • HuFQJiangSPDuYZPreparation and characteristics of monostearin nanostructured lipid carriersInt J Pharm20063141838916563671
  • YuanHWangLLDuYZPreparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsificationColloids Surf B Biointerfaces200760217417917656075
  • IqbalMAMdSSahniJKNanostructured lipid carriers system: recent advances in drug deliveryJ Drug Target2012201081383022931500
  • WeberSZimmerAPardeikeJSolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the artEur J Pharm Biopharm201486172224007657
  • WangYZhangHHaoJLung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effectDrug Deliv20162341398140326079530
  • BaiJXuJZhaoJZhangRHyaluronan and calcium carbonate hybrid nanoparticles for colorectal cancer chemotherapyMater Res Express201749095401
  • XiaQLiLZhaoLSilica nanoparticle-based dual-responsive nanoprodrug system for liver cancer therapyExp Ther Med20171432071207728962126
  • TangDZhaoXYangTWangCPaclitaxel prodrug based mixed micelles for tumor-targeted chemotherapyRSC Adv201881380389
  • ZhengTWangAHuDWangYTumor-targeting templated silica nanoparticles as a dual-drug delivery system for anti-angiogenic ovarian cancer therapyExp Ther Med20171432162217028962137
  • WanJWuWZhangRLiuSHuangYAnti-EGFR antibody conjugated silica nanoparticles as probes for lung cancer detectionExp Ther Med20171443407341229042926
  • WangCBaoXDingXA multifunctional self-dissociative polyethyleneimine derivative coating polymer for enhancing the gene transfection efficiency of DNA/polyethyleneimine polyplexes in vitro and in vivoPolym Chem201565780796
  • AbbadSWangCWaddadAYLvHZhouJPreparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly (butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrateInt J Nanomedicine20151030532025609946
  • WangCLiMYangTA self-assembled system for tumor-targeted co-delivery of drug and geneMater Sci Eng C Mater Biol Appl20155628028526249591
  • DingXXuXZhaoYTumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancerRSC Adv20177563508635095
  • DongXMattinglyCATsengMTDoxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATPCancer Res20096993918392619383919
  • WuMMengQChenYLarge pore-sized hollow mesoporous organosilica for redox-responsive gene delivery and synergistic cancer chemotherapyAdv Mater201628101963196926743228
  • ShiahSGChuangSEChauYPShenSCKuoMLActivation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathwayCancer Res19995923913989927052
  • CalvielloGDi NicuoloFSeriniSDocosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracilCancer Chemother Pharmacol2005551122015365767
  • ChengCZhangXMengYChenLZhangQDevelopment of a dual drug-loaded hydrogel delivery system for enhanced cancer therapy: in situ formation, degradation and synergistic antitumor efficiencyJ Mater Chem B201754384878497
  • XuLZhaoMYangYA reactive oxygen species (ROS)-responsive low molecular weight gel co-loaded with doxorubicin and Zn(ii) phthalocyanine tetrasulfonic acid for combined chemo-photodynamic therapyJ Mater Chem B201754691579164
  • WangCChenSWangYLipase-Triggered Water-Responsive “Pandora’s Box” for Cancer Therapy: Toward Induced Neighboring Effect and Enhanced Drug PenetrationAdvanced Materials201830141706407
  • BaiJXuJZhaoJZhangRHyaluronan and calcium carbonate hybrid nanoparticles for colorectal cancer chemotherapyMaterials Research Express201749095401